BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Arthritis
,
Hypothalamus
,
Laser capture microdissection
,
Doxorubicin
,
rs2300478
,
EGFR
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Chop
Summary
General Info
Curated Studies
Most Correlated Studies
Lymph nodes from diffuse large B-cell lymphoma (DLBCL) patients
Diffuse large B cell lymphomas linked with outcomes following CHOP chemotherapy
Distinct molecular features of mature aggressive lymphomas and their response to therapy
OMIM - CHOPS syndrome
Embryonic fibroblasts with CHOP or ATF5 perturbations
Explore Curated Studies Results
Literature
Most Relevant Literature
NOTCH1 Mutations Inhibit Tumor Growth in the Esophageal Epithelium.
Notch1 mutations drive clonal expansion in normal esophageal epithelium but impair tumor growth.
NOTCH1 loss of the TAD and PEST domain: An antimorph?
Optogenetic control of NOTCH1 signaling.
Notch1 signaling is limited in healthy mature kidneys in vivo.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL
Prevention of CHOP-induced Chronic Cardiotoxicity
Parsaclisib in Combination With CHOP in Participants With Previously Untreated PTCL
Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma
Tucidinostat, Azacitidine Combined With CHOP Versus CHOP in Patients With Untreated Peripheral T-cel…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ